Inventor · disambiguated record
Xiong Cai
Also filed as: CAI XIONG
77 granted patents·24 pending applications·999 citations·filing 1992–2024
99Inventor score
Top patents by PatentIndex Score
101 records- 0196US8461157B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCAI XIONG·Filed 2011·Granted Jun 11, 2013·27 cites·19 claims
- 0295US8906909B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2013·Granted Dec 9, 2014·17 cites·20 claims
- 0395US8563741B2CDK inhibitors containing a zinc binding moietyQIAN CHANGGENG·Filed 2008·Granted Oct 22, 2013·23 cites·11 claims
- 0495US7547781B2Quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2007·Granted Jun 16, 2009·15 cites·9 claims
- 0595US5780503ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Jul 14, 1998·76 cites·6 claims
- 0694US5792776ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1994·Granted Aug 11, 1998·58 cites·30 claims
- 0794US5750565ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted May 12, 1998·66 cites·29 claims
- 0893US10676482B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2019·Granted Jun 9, 2020·3 cites·4 claims
- 0992US8710219B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCAI XIONG·Filed 2012·Granted Apr 29, 2014·14 cites·8 claims
- 1092US8367663B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2010·Granted Feb 5, 2013·17 cites·25 claims
- 1191US10336770B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2017·Granted Jul 2, 2019·7 cites·13 claims
- 1291US5434151ACompounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenaseCYTOMED INC·Filed 1992·Granted Jul 18, 1995·89 cites·27 claims
- 1391US5358938ACompounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenaseCYTOMED INC·Filed 1992·Granted Oct 25, 1994·70 cites·25 claims
- 1491US2025230169A1Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding MoietyCURIS INC·Filed 2024·Application pending·0 cites
- 1590US9725461B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2014·Granted Aug 8, 2017·11 cites·18 claims
- 1690US5703093ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Dec 30, 1997·55 cites·22 claims
- 1789US8324240B2Fused amino pyridine as HSP90 inhibitorsCAI XIONG·Filed 2008·Granted Dec 4, 2012·7 cites·14 claims
- 1888US9657032B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2015·Granted May 23, 2017·5 cites·21 claims
- 1988US9249156B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2014·Granted Feb 2, 2016·6 cites·9 claims
- 2088US8586605B2Fused amino pyridine as HSP90 inhibitorsCAI XIONG·Filed 2012·Granted Nov 19, 2013·6 cites·25 claims
- 2188US8455506B2Quinazoline based EGFR inhibitors containing a zinc binding moietyQIAN CHANGGENG·Filed 2009·Granted Jun 4, 2013·9 cites·10 claims
- 2288US7977347B2Quinazoline based EGFR inhibitorsCURIS INC·Filed 2007·Granted Jul 12, 2011·11 cites·10 claims
- 2387US8604044B2Quinazoline based EGFR inhibitors containing a zinc binding moietyQIAN CHANGGENG·Filed 2007·Granted Dec 10, 2013·4 cites·12 claims
- 2487US5463083ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1994·Granted Oct 31, 1995·67 cites·27 claims
- 2586US6423842B1Muscarinic agonists and antagonistsUCB SA·Filed 2001·Granted Jul 23, 2002·20 cites·3 claims
- 2686US2023192687A1Fused amino pyridine as hsp90 inhibitorsCURIS INC·Filed 2022·Application pending·0 cites
- 2785US2023227467A1Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2023·Application pending·0 cites
- 2884US8119616B2Formulation of quinazoline based EGFR inhibitors containing a zinc binding moietyCAI XIONG·Filed 2008·Granted Feb 21, 2012·3 cites·54 claims
- 2984US5856323ACompounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenaseCYTOMED INC·Filed 1995·Granted Jan 5, 1999·62 cites·18 claims
- 3084US5741809ACompounds and methods for the treatment of cardiovascular inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Apr 21, 1998·55 cites·7 claims
- 3183US11597732B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2022·Granted Mar 7, 2023·0 cites·6 claims
- 3283US8846912B2Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2013·Granted Sep 30, 2014·2 cites·17 claims
- 3383US8273785B2Substituted 2-indolinone as PTK inhibitors containing a zinc binding moietyCAI XIONG·Filed 2011·Granted Sep 25, 2012·5 cites·8 claims
- 3483US7846938B2Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2008·Granted Dec 7, 2010·4 cites·25 claims
- 3583US5648486ACompounds and methods for the treatment of inflammatory and immune disordersCYTOMED INC·Filed 1993·Granted Jul 15, 1997·55 cites·30 claims
- 3682US9169244B2Tyrosine kinase inhibitors containing a zinc binding moietyCURIS INC·Filed 2013·Granted Oct 27, 2015·4 cites·10 claims
- 3782US7888361B2Tyrosine kinase inhibitors containing a zinc binding moietyCURIS INC·Filed 2007·Granted Feb 15, 2011·4 cites·9 claims
- 3881US10428068B2Fused amino pyridine as HSP90 inhibitorsCURIS INC·Filed 2018·Granted Oct 1, 2019·1 cites·2 claims
- 3980US10543197B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2018·Granted Jan 28, 2020·1 cites·6 claims
- 4080US8518910B2Formulation of quinazoline based EGFR inhibitors containing a zinc binding moietyCAI XIONG·Filed 2012·Granted Aug 27, 2013·2 cites·26 claims
- 4180US6686502B1Compounds and methods for treatment of asthma, allergy and inflammatory disordersUCB SA·Filed 2003·Granted Feb 3, 2004·10 cites·1 claims
- 4280US6555550B1Musarinic agonists and antagonistsUCB SA·Filed 2002·Granted Apr 29, 2003·9 cites·3 claims
- 4379US11654136B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2021·Granted May 23, 2023·0 cites·12 claims
- 4479US6323194B1Muscarinic agonists and antagonistsUCB SA·Filed 2000·Granted Nov 27, 2001·10 cites·8 claims
- 4578US7928136B2Substituted 2-indolinone as PTK inhibitors containing a zinc binding moietyCURIS INC·Filed 2007·Granted Apr 19, 2011·2 cites·11 claims
- 4678US6251916B1Muscarinic agonists and antagonistsUCB SA·Filed 2000·Granted Jun 26, 2001·9 cites·6 claims
- 4777US11560377B2Fused amino pyridine as HSP90 inhibitorsCURIS INC·Filed 2020·Granted Jan 24, 2023·0 cites·3 claims
- 4877US11261195B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2020·Granted Mar 1, 2022·0 cites·8 claims
- 4976US10844056B2Fused amino pyridine as HSP90 inhibitorsCURIS INC·Filed 2019·Granted Nov 24, 2020·0 cites·3 claims
- 5076US6451801B1Compounds and methods for treatment of asthma, allergy and inflammatory disordersUCB SA·Filed 2000·Granted Sep 17, 2002·9 cites·22 claims
Showing the top 50 of 101 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xiong Cai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →